fashion -WSS

fashion

author：focus 2025-09-05 13:27:27 - browse：621

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： What to do when lifesaving products contribute to climate change

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

Why does health care cost so much? A reading guide

Pediatric cancer treatments threatened by a new FDA policy

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Why does health care cost so much? A reading guide

Will the market for weight loss drugs really reach $100 billion?

hotspot

fashion

focus

At least 13 dead in Texas as scorching temps continue

UnitedHealth’s Optum accused of antitrust violations in California

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA investigates CAR

Medicare details structure of new drug price negotiation program

Diversity in clinical trials starts with building trust, experts say

Trump demands the U.S. pay no more for drugs than other countries … again

ReNAgade cuts staff seven months after raising $300 million

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How to pay for weight loss drugs and save Medicare

focus

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

CDC director unscathed in first congressional testimony

H5N1 bird flu virus started spreading in cows in Texas in December

What to do when lifesaving products contribute to climate change

What don’t we know about an Alzheimer’s drug side effect?

UnitedHealth financials solid despite Change Healthcare cyberattack

explore

hotspot

entertainment

entertainment